Meghan Arwood, BSPharm, PharmD received her BS and PharmD degrees from the University of Florida (UF) (2010; 2013) and completed a PGY1 Pharmacy Practice Residency at Holmes Regional Medical Center in Melbourne, Florida (2014). Following residency, she started a fellowship in translational pharmacogenomics at the University of Illinois at Chicago (UIC) and completed it at UF (2016). Arwood became a board-certified pharmacotherapy specialist (2017) and received a MS degree in Clinical and Translational Science from UIC (2018). Her thesis research focused on transcriptomic predictors of pulmonary hypertension development in heart failure patients. In 2017, Dr. Arwood joined the Department of Pharmacotherapy and Translational Research in the UF College of Pharmacy as a Clinical Assistant Professor. In this role, she supported the implementation of pharmacogenomics through UF Health’s Precision Medicine Program. Dr. Arwood directed a pharmacogenetics consult clinic within internal medicine for two and a half years. In clinic, she frequently encountered drug-drug-gene interactions in patients with polypharmacy; however, guidance on handling these interactions was limited. In April 2020, Dr. Arwood transitioned to her current position of Clinical Research Scientist with TRHC at their Precision Pharmacotherapy Research & Development Institute in Orlando, Florida, where she has a role maintaining and updating TRHC’s clinical decision support system of drug-drug interactions, a tool that aims to guide healthcare providers in handling similar drug interactions that she encountered in clinic.